Methsuximide
Back to searchMolecule Structure
Scientific Name
Methsuximide
Description of the Drug
Methsuximide is a succinimide anticonvulsant that increases the seizure threshold. Primarily used for childhood absence seizures. Functions by suppressing paroxysmal spike-and-wave patterns associated with lapses of consciousness in absence seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05246
http://www.drugbank.ca/drugs/DB05246
Brand Name(s)
Celontin
Company Owner(s)
Parke Davis Div Warner Lambert Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Voltage-gated T-type calcium channel | PROTEIN FAMILY | BLOCKER | CHEMBL2362995 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34852 | |
PharmGKB | PA164743145 | |
Human Metabolome Database | HMDB0015611 | |
DrugBank | DB05246 | |
PubChem: Thomson Pharma | 15171756 | |
PubChem | 6476 | |
Mcule | MCULE-6225403857 | |
Nikkaji | J4.203J | |
EPA CompTox Dashboard | DTXSID5023293 | |
DrugCentral | 1758 | |
ChemicalBook | CB2695398 | |
Guide to Pharmacology | 7228 | |
rxnorm | CELONTIN | METHSUXIMIDE |
ChEBI | 6846 |